Clinical Trials Update: Jan. 21, 2010Last Updated: January 21, 2010.
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Heartburn Related to Gastroesophageal Reflux Disease (GERD)
This study will evaluate the effectiveness of using dexlansoprazole MR in people with gastroesophageal reflux disease whose symptoms are well-controlled on twice daily proton pump inhibitors.
The research site is in San Ramon, Calif.
COPD (Chronic Obstructive Pulmonary Disease)
This is a 52-week study to test the safety and tolerability of NVA237 in people with chronic obstructive pulmonary disease (COPD). You must be 40 or older and have stable moderate-to-severe COPD to qualify.
The research site is in Montgomery, Ala.
This study is for women who have migraines during the menstrual cycle. To qualify, you must be female, aged 18 to 34, and have migraines during the menstrual period.
The research site is in San Antonio, Texas.
Copyright 2010 ClinicalConnection.com. All rights reserved.
|Previous: Scientists Read Brain’s Magnetic Fields to Spot PTSD||Next: Health Highlights: Jan. 21, 2010|
Reader comments on this article are listed below. Review our comments policy.